TMCnet News
Research and Markets: Peptide Therapeutics Market (by Applications, by Route of Administration, and by Marketing Status) - Global Industry Analysis 2014 - 2020Research and Markets (http://www.researchandmarkets.com/research/w7kktc/peptide) has announced the addition of the "Peptide Therapeutics Market (by Applications, by Route of Administration, and by Marketing Status) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. The global peptide therapeutics market is largely concentrated in the western countries of North America and Europe, which account for more than 60% of the market share. Although these regions are currently the largest market segments, the compounded annual growth rate of the market in these regions is expected to be slower as compared to Asia Pacific. India, China and Japan are major countries driving the peptide therapeutics market in the Asia Pacific region. Japan is the second-largest individual pharmaceutical market, while India and China have large patient population due to high disease prevalence. Rapidly developing economy and increasing awareness about various disease treatments are other factors driving the market. India and China have emerged as major eptide API suppliers globally. Patent expiry has been the prime factor impeding market growth; while at the same time has also allowed deeper market penetration in low and middle income countries. The market is also restrained due to unavailability of convenient routes of drug administration, and lower drug stability at room temperature. Scientists, however, are trying to overcome these drawbacks through consistent research and development. With an escalating number of peptide therapeutic drug approvals and consistent launch of generics, the demand for peptide APIs is expected to rise in the near future. Hence, API manufacturers are trying to optimize economies of scale to reduce costs and also meet the rising peptide API demand. Thus, the supply side of the peptide therapeutics value chain would decide the fate of the global market. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Peptide Therapeutics Market Overview Chapter 4 Global Peptide Therapeutics Market, by Applications Chapter 5 Global Peptide Therapeutics Market, by Route of Administration Chapter 6 Global Peptide Therapeutics Market, by Marketing Status Chapter 7 Global Peptide Therapeutics Pipeline Overview Chapter 8 Global Peptide Therapeutics Market, by Geography Chapter 9 Recommendations Chapter 10 Company Profiles - Amgen, Inc. - AstraZeneca plc - Bachem Holding AG - CordenPharma International GmbH - Eli Lilly and Company - Ipsen S.A. - Lonza Group Ltd. - Merck & Co., Inc. - Novartis AG - Novo Nordisk A/S - PolyPeptide Group - Roche Holdings AG - Sanofi - Takeda Pharmaceutical Company Limited - Teva Pharmaceutical Industries Ltd. For more information visit http://www.researchandmarkets.com/research/w7kktc/peptide
View source version on businesswire.com: http://www.businesswire.com/news/home/20150526005977/en/ |
